Conmed (CNMD) Shares Outstanding (2010 - 2026)

Conmed (CNMD) has reported Shares Outstanding (Entity) for 17 consecutive years, with $30.0 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Shares Outstanding (Entity) fell 3.24% year-over-year to $30.0 million; the trailing twelve-month figure through Jun 2026 stood at $30.0 million (down 3.24% YoY), and the FY2025 full-year result was $30.8 million, changed 0.24% from the prior year.
• Shares Outstanding (Entity) fell to $30.0 million in Q2 2026 per CNMD's latest filing, from $30.1 million in the prior quarter.
• Across five years, Shares Outstanding (Entity) topped out at $31.0 million in Q3 2025 and bottomed at $29.5 million in Q1 2022.
• Historically, Shares Outstanding (Entity) has averaged $30.6 million across 5 years, with a median of $30.8 million in 2023.
• The sharpest annual moves came in 2022 and 2026: Shares Outstanding (Entity) grew 4.47% in 2022, then decreased 3.24% in 2026.
• Over 5 years, Shares Outstanding (Entity) stood at $30.5 million in 2022, then climbed by 0.92% to $30.8 million in 2023, then gained by 0.42% to $30.9 million in 2024, then declined by 0.24% to $30.8 million in 2025, then decreased by 2.86% to $30.0 million in 2026.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $30.0 million, $30.1 million, and $30.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.